SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

27 Jul 2022 Evaluate
The sales surged to Rs. 449.44 millions, up 38.55% for the June 2022 quarter as against Rs. 324.40 millions during the corresponding quarter previous year.A good growth in profit of 37.51% reported to Rs. 177.71  millions over Rs. 129.23 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 242.02 millions from 178.57 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 449.44 324.40 38.55 449.44 324.40 38.55 1148.54 905.63 26.82
Other Income 14.23 11.33 25.60 14.23 11.33 25.60 40.50 32.67 23.97
PBIDT 242.02 178.57 35.53 242.02 178.57 35.53 620.95 435.95 42.44
Interest 0.62 1.96 -68.37 0.62 1.96 -68.37 8.28 9.81 -15.60
PBDT 241.40 176.61 36.69 241.40 176.61 36.69 612.67 426.14 43.77
Depreciation 5.70 5.41 5.36 5.70 5.41 5.36 22.33 17.32 28.93
PBT 235.70 171.20 37.68 235.70 171.20 37.68 590.34 408.82 44.40
TAX 57.99 41.97 38.17 57.99 41.97 38.17 154.10 107.02 43.99
Deferred Tax -1.92 -0.42 357.14 -1.92 -0.42 357.14 0.72 1.26 -42.86
PAT 177.71 129.23 37.51 177.71 129.23 37.51 436.24 301.80 44.55
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 53.85 55.05 -2.17 53.85 55.05 -2.17 54.06 48.14 12.31

Guj. Themis Biosyn Share Price

319.45 15.45 (5.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×